Table 2 Anthropometric measurements and metabolic profile of the participants (N = 290)
Characteristics | MetS (n = 55) | No MetS (n = 235) | P value* |
|---|---|---|---|
Urine adiponectin (ng/mL) | 2.6 ± 2.2 | 2.3 ± 1.9 | 0.55 |
Systolic BP (mmHg) | 134.2 ± 9.9 | 122.5 ± 13.3 | < 0.001 |
Diastolic BP (mmHg) | 80.6 ± 13.7 | 75.1 ± 10.9 | 0.02 |
Anthropometric measurements | |||
Body weight (kg) | 64.4 ± 9.3 | 56.3 ± 9.6 | < 0.001 |
Height (cm) | 155.3 ± 5.3 | 155.6 ± 6.9 | 0.79 |
BMI (kg/m2) | 26.8 ± 3.9 | 23.1 ± 3.5 | < 0.001 |
Waist circumference (cm) | 87.6 ± 7.8 | 78.2 ± 9.2 | < 0.001 |
Hip circumference (cm) | 102.5 ± 9.2 | 95.9 ± 7.9 | < 0.001 |
Waist-to-hip ratio (WHR) | 0.85 ± 0.1 | 0.81 ± 0.1 | < 0.001 |
Overweight and obesity, n (%) | 36 (65.5) | 53 (22.5) | < 0.001 |
Abdominal obesity, n (%) | 50 (90.5) | 86 (36.6) | < 0.001 |
Body fat distribution pattern, n (%) | |||
Gynoid (WHR < 0.85) | 29 (52.7) | 187 (79.6) | < 0.001 |
Android (WHR ≥ 0.85) | 26 (47.3) | 48 (20.2) | |
Metabolic profiles | |||
Fasting blood sugar (mg/dL) | 114.1 ± 34.4 | 93.9 ± 8.6 | < 0.001 |
Total cholesterol (mg/dL) | 237.2 ± 44.3 | 226.6 ± 41.6 | 0.096 |
HDL (mg/dL) | 54.6 ± 12.9 | 69.2 ± 15.3 | < 0.001 |
LDL (mg/dL) | 154.1 ± 39.6 | 140.5 ± 35.9 | 0.014 |
Triglyceride (mg/dL) | 166.6 ± 75.8 | 94.7 ± 38.0 | < 0.001 |